Skip to main content
OpenTrials

Clinical trial condition

Ovarian Diseases

Explore clinical trials studying Ovarian Diseases. Study availability and eligibility vary by location and protocol.

3,406 public trials 661 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Diseases trial results

Completed

A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer

NCT00913835

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • ImClone Investigational Site Joliet, Illinois, United States
  • ImClone Investigational Site Indianapolis, Indiana, United States
  • ImClone Investigational Site Baltimore, Maryland, United States
  • ImClone Investigational Site Boston, Massachusetts, United States
View Trial Details
Completed

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT01666444

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +26 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Winthrop P. Rockefeller Cancer Institute - University of Arkansas Little Rock, Arkansas, United States
  • Providence Saint Joseph Medical Center Burbank, California, United States
  • Kaiser Permanente Medical Center Hayward, California, United States
View all 136 locations
View Trial Details
Completed

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

NCT01059643

Conditions
Adnexal Diseases, Bronchial Neoplasms, Cancer of Head and Neck, +46 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jonesboro, Arkansas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Macon, Georgia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Marietta, Georgia, United States
View all 18 locations
View Trial Details
Completed

A Study LY2228820 for Recurrent Ovarian Cancer

NCT01663857

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • St Josephs Hospital and Medical Center Phoenix, Arizona, United States
  • Arizona Oncology Associates, P.C. Tucson, Arizona, United States
  • Sarasota Memorial Hospital Sarasota, Florida, United States
  • H Lee Moffitt Cancer Center Tampa, Florida, United States
View all 30 locations
View Trial Details

Related conditions